Skip to main content
SERA filings

Corporate insider profile

Tiffany Eul Davis Inglis Filing Activity

Latest reported as Chief Medical Officer of SERA PROGNOSTICS, INC. (SERA).

Purchase filings
0
Reported companies
1
Net open-market value
-$727.62
Latest transaction
Jun 11, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 11, 2026SERA PROGNOSTICS, INC. (SERA)Chief Medical OfficerSale362$2.01$727.62